Home > Income Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Consolidated Net Profit

    Back to Income Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

MEDICAMEN BIOTECH Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹9.49 Cr₹15 Cr₹15 Cr₹1,212,944 Cr₹13 Cr

What is the latest Consolidated Net Profit of MEDICAMEN BIOTECH ?

The latest Consolidated Net Profit ratio of MEDICAMEN BIOTECH is ₹9.49 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹9.49 Cr
Mar2024₹15 Cr
Mar2023₹15 Cr
Mar2022₹1,212,944 Cr
Mar2021₹13 Cr

How is Consolidated Net Profit of MEDICAMEN BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹9.49 Cr
-35.54
Mar2024 ₹15 Cr
-1.13
Mar2023 ₹15 Cr
-100.00
Mar2022 ₹1,212,944 Cr
9,125,955.15
Mar2021 ₹13 Cr -

Compare Consolidated Net Profit of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹468.0 Cr -2.3% -12.4% -32.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,402.0 Cr 1.2% -0.9% -1.8% Stock Analytics
DIVIS LABORATORIES ₹164,277.0 Cr 2.7% -3.8% 5.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,140.0 Cr 2.1% 2.8% 30.9% Stock Analytics
CIPLA ₹107,398.0 Cr -0.1% -8.2% -8.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,378.0 Cr 2.7% 7.1% 2.8% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-2.3%

-12.4%

-32.9%

SENSEX

0.4%

-0.2%

6.9%


You may also like the below Video Courses